Extensive evidence supports the notion that activation of the STING/TBK1 pathway significantly enhances anti‐tumor immune responses.[38] The results of this study demonstrate that nanocarrier‐mediated FABP5 knockout effectively amplifies the anti‐tumor immune effects of RFA via activation of the STING/TBK1 pathway. The gene discussed is STING1; the disease is neoplasm.